Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL192064 | 0.87 | PTGS2 (0.53) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL6195246 | 0.87 | GAA (0.49) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL9686940 | 0.85 | GAA (0.45) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL18932889 | 0.78 | ALDH1A1 (0.44) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL28257930 | 0.75 | TPMT (0.60) | GAAKMT2AKDM4EPTGS2HTT | |
| SCHEMBL7046945 | 0.73 | PTGS2 (0.57) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL8931216 | 0.73 | PTGS2 (0.48) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL16933701 | 0.73 | ALDH1A1 (0.50) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL4965033 | 0.72 | PTGS2 (0.55) | GAAKMT2AKDM4EPTGS2MEN1 | |
| SCHEMBL499116 | 0.72 | GAA (0.61) | GAAKMT2AKDM4EPTGS2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6818643-B1 | 3,9-DIAZABICYCLO(3.3.1)NONAN-2-ONE DERIVATIVES; PEPTIDYL-PROLYL ISOMERASE (PPIASE OR ROTAMASE) INHIBITORS; NEUROPROTECTIVE AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2004-11-16 | — | — | US | disclosed |
| EP-1087763-A4 | NEUROTROPHIC DIFLUOROAMIDE AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2002-10-31 | — | — | EP | disclosed |
| WO-2001042245-A1 | NEUROTROPHIC BICYCLIC DIAMIDES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
| US-6239146-B1 | PEPTIDYL-PROLYL ISOMERASE (PPIASE OR ROTAMASE) INHIBITORY ACTIVITY OF NOVEL .ALPHA.,.ALPHA.-DIFLUOROACETAMIDO COMPOUNDS, BIND TO IMMUNOPHILINS SUCH AS FKBP12 AND INHIBIT THEIR ROTAMASE ACTIVITY. | BRISTOL-MYERS SQUIBB COMPANY | 2001-05-29 | — | — | US | disclosed |
| EP-1087763-A1 | NEUROTROPHIC DIFLUOROAMIDE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-04-04 | — | — | EP | disclosed |
| US-6096762-A | CONTACTING NERVE CELLS WITH A NEUROTROPHIC AMOUNT OF DIFLUOROAMIDE COMPOUND WITH AFFINITY FOR AN FK-506 BINDING PROTEIN FOR STIMULATING NEURITE GRWOTH IN NERVE CELLS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-08-01 | — | — | US | disclosed |
| WO-1999062511-A1 | NEUROTROPHIC DIFLUOROAMIDE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-12-09 | — | — | WO | disclosed |